Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (171-180 of 257) with videos related to

Pageof 26
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacinA L Barry, P C Fuchs, D M Citron, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Quality control parameters for broth microdilution susceptibility testing of amoxicillin and amoxicillin-clavulanic acidA L Barry, S D Allen, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1994
Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853A L Barry, S D Allen, P C Fuchs, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
American Journal of Clinical Pathology|October 1, 1979
Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobicsR N Jones, P C Fuchs, C Thornsberry, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Desacetylcefotaxime--another broad spectrum cephalosporin?P C Fuchs, R N Jones, A L Barry, et al.
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
Pageof 26

Showing results (171-180 of 257) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacinA L Barry, P C Fuchs, D M Citron, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Quality control parameters for broth microdilution susceptibility testing of amoxicillin and amoxicillin-clavulanic acidA L Barry, S D Allen, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1994
Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853A L Barry, S D Allen, P C Fuchs, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
American Journal of Clinical Pathology|October 1, 1979
Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobicsR N Jones, P C Fuchs, C Thornsberry, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Desacetylcefotaxime--another broad spectrum cephalosporin?P C Fuchs, R N Jones, A L Barry, et al.
American Journal of Clinical Pathology|December 1, 1978
Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1995
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)D L Sewell, A L Barry, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1977
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
Pageof 26